180 related articles for article (PubMed ID: 6593107)
21. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
[TBL] [Abstract][Full Text] [Related]
22. Interaction of peptides present in perivascular nerves on the smooth muscle of cat cerebral arteries and on the stimulation-evoked efflux of 3H-noradrenaline.
Edvinsson L; Skärby T
J Auton Pharmacol; 1984 Sep; 4(3):193-8. PubMed ID: 6593321
[TBL] [Abstract][Full Text] [Related]
23. The selective potentiation of noradrenaline-induced tone by Bay K 8644 in the rabbit basilar artery.
Laher I; Germann P; Dowd AL; Bevan JA
J Cereb Blood Flow Metab; 1989 Dec; 9(6):759-64. PubMed ID: 2479650
[TBL] [Abstract][Full Text] [Related]
24. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
Gradin KA; Li JY; Andersson O; Simonsen U
J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
[TBL] [Abstract][Full Text] [Related]
25. Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries.
Abel PW; Han C
J Cardiovasc Pharmacol; 1989 Jan; 13(1):52-63. PubMed ID: 2468936
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
Edvinsson L; Adamsson M; Jansen I
Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.
Dahlöf C; Dahlöf P; Tatemoto K; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):327-30. PubMed ID: 3838576
[TBL] [Abstract][Full Text] [Related]
28. Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries.
Prieto D; Hernández M; Rivera L; García-Sacristán A; Simonsen U
Regul Pept; 1997 Apr; 69(3):155-65. PubMed ID: 9226400
[TBL] [Abstract][Full Text] [Related]
29. Selective potentiation of extracellular Ca2+-dependent contraction by neuropeptide Y in rabbit mesenteric arteries.
Oshita M; Kigoshi S; Muramatsu I
Gen Pharmacol; 1989; 20(3):363-7. PubMed ID: 2545512
[TBL] [Abstract][Full Text] [Related]
30. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
[TBL] [Abstract][Full Text] [Related]
31. Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter.
Glover WE
Clin Exp Pharmacol Physiol; 1985; 12(3):227-30. PubMed ID: 3839723
[TBL] [Abstract][Full Text] [Related]
32. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
Owen MP
J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
[TBL] [Abstract][Full Text] [Related]
33. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
Xia J; Neild TO; Kotecha N
Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974
[TBL] [Abstract][Full Text] [Related]
34. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J; Svenberg T; Lundberg JM
Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
[TBL] [Abstract][Full Text] [Related]
35. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery.
Lundberg JM; Pernow J; Tatemoto K; Dahlöf C
Acta Physiol Scand; 1985 Apr; 123(4):511-3. PubMed ID: 3838851
[No Abstract] [Full Text] [Related]
36. Pre- and postjunctional effects of neuropeptide Y on the rabbit isolated ear artery.
Wong-Dusting HK; Rand MJ
Clin Exp Pharmacol Physiol; 1988 May; 15(5):411-8. PubMed ID: 3271616
[TBL] [Abstract][Full Text] [Related]
37. Renal arterial reactivity to potassium, noradrenaline, and neuropeptide Y and association with urinary albumin excretion in the diabetic rat.
Torffvit O; Adamsson M; Edvinsson L
J Diabetes Complications; 1997; 11(5):279-86. PubMed ID: 9334910
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y (NPY) in the orbital arteries of the rabbit. Immunocytochemistry and vasomotor activity.
Elsås T; Uddman R; Junping Y; Edvinsson L
Acta Ophthalmol Scand; 1995 Dec; 73(6):517-20. PubMed ID: 9019375
[TBL] [Abstract][Full Text] [Related]
39. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?
Wahlestedt C; Håkanson R
Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392
[TBL] [Abstract][Full Text] [Related]
40. Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit.
Högestätt ED; Andersson KE; Edvinsson L
Acta Physiol Scand; 1982 Feb; 114(2):283-96. PubMed ID: 6127868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
